look at the chart........the recent RM research report reckons this is the most undervalued junior they have seen in the last 10 years..........accessible on the TRH thread. Enjoy!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%